Evidence map›Paper›PMID 25447411›Full record

ArticleToxicology and applied pharmacology2015

Analysis of the AHR gene proximal promoter GGGGC-repeat polymorphism in lung, breast, and colon cancer.

Barbara C Spink, Michael S Bloom, Susan Wu, Stewart Sell, Erasmus Schneider, Xinxin Ding, David C Spink

Abstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Structure-Activity Relationships of the Main Bioactive Constituents ofDrug metabolism and disposition: the biological fate of chemicals · 2018
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Barbara C SpinkWadsworth Center, New York State Department of Health, Albany, NY 12201, United States.
Michael S BloomDepartment of Environmental Health Sciences, School of Public Health, University at Albany, State University of New York, Albany, NY 12201, United States.
Susan WuWadsworth Center, New York State Department of Health, Albany, NY 12201, United States.
Stewart SellWadsworth Center, New York State Department of Health, Albany, NY 12201, United States; Department of Biomedical Sciences, School of Public Health, University at Albany, State University of New York, Albany, NY 12201, United States.
Erasmus SchneiderWadsworth Center, New York State Department of Health, Albany, NY 12201, United States; Department of Biomedical Sciences, School of Public Health, University at Albany, State University of New York, Albany, NY 12201, United States.
Xinxin DingWadsworth Center, New York State Department of Health, Albany, NY 12201, United States; Department of Environmental Health Sciences, School of Public Health, University at Albany, State University of New York, Albany, NY 12201, United States; Department of Biomedical Sciences, School of Public Health, University at Albany, State University of New York, Albany, NY 12201, United States.
David C SpinkWadsworth Center, New York State Department of Health, Albany, NY 12201, United States; Department of Environmental Health Sciences, School of Public Health, University at Albany, State University of New York, Albany, NY 12201, United States. Electronic address: spink@wadsworth.org.
Albany State University · USNew York State Department of Health · USUniversity at Albany, State University of New York · US

Funding

The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areasP51OD011133 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Larry S. Schlesinger · 2012 to 2026
$129.7M
WNV REPLIVAX VACCINE IN NON-HUMAN PRIMATESP51RR013986 · NCRR · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI GAUDUIN, MARIE-CLAIRE ELISABETH · 1999 to 2011
$79.1M
Human CYP2A and respiratory tract xenobiotic toxicityR01CA092596 · NCI · WADSWORTH CENTER · PI DING, XINXIN · 2003 to 2020
$6.1M
Developmental Infrastructure CoreR24HD044943 · NICHD · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI GAGE, TIMOTHY B · 2004 to 2016
$4.8M
Carcinogenicity of EstrogensR01CA081243 · NCI · WADSWORTH CENTER · PI SPINK, DAVID C · 2000 to 2009
$1.9M
Impact of proximal promoter polymorphisms on AHR gene expression in human lungR03CA170960 · NCI · WADSWORTH CENTER · PI SPINK, DAVID C · 2013 to 2014
$135k
NCI NIH HHS CA081243NCI NIH HHS CA092596NCI NIH HHS CA170960NCI NIH HHS R01 CA081243NCI NIH HHS R01 CA092596NCI NIH HHS R03 CA170960NCRR NIH HHS P51 RR013986NICHD NIH HHS R24 HD044943NIH HHS P51 OD011133
6 · The paper itself

Abstract

The aryl hydrocarbon receptor (AhR) regulates expression of numerous genes, including those of the CYP1 gene family. With the goal of determining factors that control AHR gene expression, our studies are focused on the role of the short tandem repeat polymorphism, (GGGGC)n, located in the proximal promoter of the human AHR gene. When luciferase constructs containing varying GGGGC repeats were transfected into cancer cell lines derived from the lung, colon, and breast, the number of GGGGC repeats affected AHR promoter activity. The number of GGGGC repeats was determined in DNA from 327 humans and from 38 samples representing 5 species of non-human primates. In chimpanzees and 3 species of macaques, only (GGGGC)2 alleles were observed; however, in western gorilla, (GGGGC)n alleles with n=2, 4, 5, 6, 7, and 8 were identified. In all human populations examined, the frequency of (GGGGC)n was n=4>5≫2, 6. When frequencies of the (GGGGC)n alleles in DNA from patients with lung, colon, or breast cancer were evaluated, the occurrence of (GGGGC)2 was found to be 8-fold more frequent among lung cancer patients in comparison with its incidence in the general population, as represented by New York State neonates. Analysis of matched tumor and non-tumor DNA samples from the same individuals provided no evidence of microsatellite instability. These studies indicate that the (GGGGC)n short tandem repeats are inherited, and that the (GGGGC)2 allele in the AHR proximal promoter region should be further investigated with regard to its potential association with lung cancer susceptibility.

Indexed as

Microsatellite RepeatsPolymorphism, GeneticPromoter Regions, GeneticAnimalsBasic Helix-Loop-Helix ProteinsBreast NeoplasmsCell Line, TumorColonic NeoplasmsCytochrome P-450 CYP1A1Cytochrome P-450 CYP1B1Enzyme InductionFemaleGene Expression Regulation, NeoplasticGene FrequencyGenes, ReporterGenetic Predisposition to DiseaseAHR protein, humanBasic Helix-Loop-Helix ProteinsCYP1A1 protein, humanCYP1B1 protein, humanCytochrome P-450 CYP1A1Cytochrome P-450 CYP1B1Receptors, Aryl HydrocarbonAryl hydrocarbon receptorBreast cancerColon cancer(GGGGC)(n) repeat polymorphismLung cancerShort tandem repeat

Identifiers

PMID25447411
PMCPMC4404625
OpenAlexW2000354716

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.